CLINICAL_TRIALS
trial_result
· 2021-09-17
Clinical Trial Update: Phase II Dose-ranging Study of Pyronaridine/Artesunate in Adults Patients With Plasmodium Falciparum Malaria [Phase 2]
Summary
Phase II dose-ranging study of Pyronaridine/Artesunate in adults with Plasmodium falciparum malaria completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medicines for Malaria Venture | Conditions: Plasmodium Falciparum Malaria | Phase 2 | Status: COMPLETED | Results posted: 2021-09-17